OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
61 hedge funds and large institutions have $336M invested in Oyster Point Pharma, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
+1
Holders Change %
+1.67%
% of All Funds
1.07%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.09%
New
9
Increased
16
Reduced
17
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$13.4M |
| 2 |
BlackRock
New York
|
+$4.27M |
| 3 |
First Manhattan
New York
|
+$3.51M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$939K |
| 5 |
JPMorgan Chase & Co
New York
|
+$879K |
Top Sellers
| 1 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$5.49M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$2.23M |
| 3 |
RI
RTW Investments
New York
|
-$1.18M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$914K |
| 5 |
Millennium Management
New York
|
-$870K |
